Biodesix, Inc. EV/Sales

EV/Sales of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.

Highlights and Quick Summary

Current EV/Sales of Biodesix, Inc. is 2.24 (as of December 31, 2021)
  • EV/Sales for the quarter ending September 30, 2022 was 1.55 (a -20.94% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -30.94%
  • Annual EV/Sales for 2021 was 2.24 (a 61.49% increase from previous year)
  • Annual EV/Sales for 2020 was 1.39 (a -27.61% decrease from previous year)
  • Annual EV/Sales for 2019 was 1.92 (a 0.0% decrease from previous year)
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of Biodesix, Inc.

Most recent EV/Salesof BDSX including historical data for past 10 years.

Interactive Chart of EV/Sales of Biodesix, Inc.

Biodesix, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 1.55 1.96 1.43 –
2021 2.24 2.86 4.46 7.47 2.24
2020 1.39 1.92 1.92 1.92 1.39
2019 – – 1.92 1.92 1.92
2018 – – – – 1.92

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research
© stockrow.com